Keith Andrew Moskowitz

This inventor holds 14 USPTO granted patents and 33 published patent applications, plus 3 CIPO patents and 1 EPO patent, primarily in Platelet Derivatives. Top assignee: Cellphire, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Andrew Moskowitz. Retrieved from https://idiyas.com/inventor/keith-andrew-moskowitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 33)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 48(Granted Patents)

Company Filing History:

14 out of 16

Cellphire, Inc.

patents

Years Active: 2022-2026

Loading Chart...

Areas of Expertise:

Platelet Derivative Compositions

Thrombosomes

Antiplatelet Agents

Hemostasis Restoration

Blood Products

Cancer Treatment

Von Willebrand Disease

Delivery Agents

Freeze-Dried Platelets

Methods of Treatment

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12702682 - Platelet derivative compositions, and methods of making and using such compositions (2026-08-11),

2. 12419914 - Thrombosomes as an antiplatelet agent reversal agent (2025-09-23),

3. 12378523 - Platelets as delivery agents (2025-08-05),

4. 12370219 - Platelet derivative compositions, and pluralities of containers containing same (2025-07-29),

5. 12295972 - Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subject (2025-05-13),

6. 12290532 - Treatment of von Willebrand disease (2025-05-06),

7. 12208122 - Methods of treating bleeding in a subject treated with an antiplatelet agent (2025-01-28),

8. 11965178 - Platelets loaded with anti-cancer agents (2024-04-23),

9. 11903971 - Treatment of von Willebrand disease (2024-02-20),

10. 11813572 - Materials and methods for producing blood products (2023-11-14),

11. 11767511 - Platelets as delivery agents (2023-09-26),

12. 11752468 - Materials and methods for producing blood products (2023-09-12),

13. 11701388 - Thrombosomes as an antiplatelet agent reversal agent (2023-07-18),

14. 11529587 - Materials and methods for producing blood products (2022-12-20),

Title: Innovator Spotlight: Keith Andrew Moskowitz

Introduction:

Keith Andrew Moskowitz, a talented inventor based in Westfield, IN (US), has made significant contributions in the field of medical advancements with a total of 7 patents to his name. His innovative work at Cellphire, Inc. showcases his dedication to improving healthcare through cutting-edge technologies.

Latest Patents:

Moskowitz's recent patents include groundbreaking inventions such as "Platelets loaded with anti-cancer agents" and "Treatment of von Willebrand disease." These patents demonstrate his expertise in developing novel methods for preparing cargo-loaded platelets and treating rare blood disorders effectively.

Career Highlights:

As a key figure at Cellphire, Inc., Moskowitz has played a crucial role in spearheading research and development initiatives that have led to transformative medical solutions. His inventive mindset and technical acumen have been instrumental in driving the company's success in creating innovative healthcare products.

Collaborations:

Moskowitz collaborates closely with talented individuals such as Amber Nicole Lee and Braden Carl Ishler to bring his ideas to life. Together, they form a dynamic team that thrives on innovation and excellence, consistently pushing the boundaries of what is possible in the field of medical science.

Conclusion:

In conclusion, Keith Andrew Moskowitz's remarkable work stands as a testament to his passion for innovation and his commitment to making a positive impact on the medical industry. With a strong record of patents and collaborations, Moskowitz continues to inspire others in the field and pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.